Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.

Mas A, Rodés J, Sunyer L, Rodrigo L, Planas R, Vargas V, Castells L, Rodríguez-Martínez D, Fernández-Rodríguez C, Coll I, Pardo A; Spanish Association for the Study of the Liver Hepatic Encephalopathy Cooperative Group.

J Hepatol. 2003 Jan;38(1):51-8.

PMID:
12480560
[PubMed - indexed for MEDLINE]
2.

Rifaximin for treatment of hepatic encephalopathy.

Maclayton DO, Eaton-Maxwell A.

Ann Pharmacother. 2009 Jan;43(1):77-84. doi: 10.1345/aph.1K436. Epub 2008 Dec 17. Review.

PMID:
19092143
[PubMed - indexed for MEDLINE]
3.

Rifaximin for the treatment of hepatic encephalopathy.

Lawrence KR, Klee JA.

Pharmacotherapy. 2008 Aug;28(8):1019-32. doi: 10.1592/phco.28.8.1019. Review.

PMID:
18657018
[PubMed - indexed for MEDLINE]
4.

Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.

Williams R, Bass N.

Rev Gastroenterol Disord. 2005;5 Suppl 1:S10-8. Review.

PMID:
15976747
[PubMed - indexed for MEDLINE]
5.

Rifaximin for the treatment of hepatic encephalopathy.

de Melo RT, Charneski L, Hilas O.

Am J Health Syst Pharm. 2008 May 1;65(9):818-22. doi: 10.2146/ajhp070298. Review.

PMID:
18436728
[PubMed - indexed for MEDLINE]
6.

Rifaximin: new therapeutic indication and future directions.

Rivkin A, Gim S.

Clin Ther. 2011 Jul;33(7):812-27. doi: 10.1016/j.clinthera.2011.06.007. Epub 2011 Jul 7. Review.

PMID:
21741091
[PubMed - indexed for MEDLINE]
7.

Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.

Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen YP, Wang L.

Eur J Gastroenterol Hepatol. 2008 Nov;20(11):1064-70. doi: 10.1097/MEG.0b013e328302f470. Review.

PMID:
19047837
[PubMed - indexed for MEDLINE]
8.

Treatment options for hepatic encephalopathy.

Schiano TD.

Pharmacotherapy. 2010 May;30(5 Pt 2):16S-21S. doi: 10.1592/phco.30.pt2.16S. Review.

PMID:
20412036
[PubMed - indexed for MEDLINE]
9.

Review article: the current pharmacological therapies for hepatic encephalopathy.

Bass NM.

Aliment Pharmacol Ther. 2007 Feb;25 Suppl 1:23-31. Review.

PMID:
17295849
[PubMed - indexed for MEDLINE]
10.

Disaccharides in the treatment of hepatic encephalopathy.

Sharma P, Sharma BC.

Metab Brain Dis. 2013 Jun;28(2):313-20. doi: 10.1007/s11011-013-9392-4. Epub 2013 Mar 2. Review.

PMID:
23456517
[PubMed - indexed for MEDLINE]
11.

Pharmacotherapy for hepatic encephalopathy.

Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A.

Drugs. 2010 Jun 18;70(9):1131-48. doi: 10.2165/10898630-000000000-00000. Review.

PMID:
20518580
[PubMed - indexed for MEDLINE]
12.

Management of hepatic encephalopathy: focus on antibiotic therapy.

Festi D, Vestito A, Mazzella G, Roda E, Colecchia A.

Digestion. 2006;73 Suppl 1:94-101. Epub 2006 Feb 8. Review.

PMID:
16498257
[PubMed - indexed for MEDLINE]
13.

Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis.

Eltawil KM, Laryea M, Peltekian K, Molinari M.

World J Gastroenterol. 2012 Feb 28;18(8):767-77. doi: 10.3748/wjg.v18.i8.767. Review.

PMID:
22371636
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Hepatic encephalopathy: pathophysiology and emerging therapies.

Sundaram V, Shaikh OS.

Med Clin North Am. 2009 Jul;93(4):819-36, vii. doi: 10.1016/j.mcna.2009.03.009. Review.

PMID:
19577116
[PubMed - indexed for MEDLINE]
15.

Combination therapy for the treatment and prevention of hepatic encephalopathy.

Mohammad RA, Regal RE, Alaniz C.

Ann Pharmacother. 2012 Nov;46(11):1559-63. doi: 10.1345/aph.1R146. Epub 2012 Oct 23. Review.

PMID:
23092866
[PubMed - indexed for MEDLINE]
16.

[Hepatic encephalopathy and liver transplantation].

Fehérvári I, Nemes B, Görög D, Gerlei Z, Kóbori L.

Magy Seb. 2012 Apr;65(2):58-62. doi: 10.1556/MaSeb.65.2012.2.4. Review. Hungarian.

PMID:
22512880
[PubMed - indexed for MEDLINE]
17.

Review article: the modern management of hepatic encephalopathy.

Bajaj JS.

Aliment Pharmacol Ther. 2010 Mar;31(5):537-47. doi: 10.1111/j.1365-2036.2009.04211.x. Epub 2009 Dec 7. Review.

PMID:
20002027
[PubMed - indexed for MEDLINE]
18.

[Diagnostics and treatment of hepatic encephalopathy].

Gillmann A, Gerharz CD, Müssig K.

Dtsch Med Wochenschr. 2012 Jan;137(1-2):29-33. doi: 10.1055/s-0031-1292864. Epub 2011 Dec 16. Review. German.

PMID:
22180281
[PubMed - indexed for MEDLINE]
19.

A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.

Soárez PC, Oliveira AC, Padovan J, Parise ER, Ferraz MB.

Arq Gastroenterol. 2009 Jul-Sep;46(3):241-7. Review.

PMID:
19918694
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk